TerminatedNot Applicable

To Evaluate if the Medication Gabapentin Lessens Vulvar Pain

Stopped: poor recruitment

United States9 participantsStarted 2007-01

Plain-language summary

The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.

Who can participate

Age range18 Years – 80 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease Clinic. Exclusion Criteria: * Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months postpartum, breast-feeding, non-English speaking, or have contraindication to use of gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).

What they're measuring

Change From Baseline in Vulvar Pain

Timeframe: 19 weeks

Trial details

NCT IDNCT00390013

SponsorColleen Stockdale

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-03

Results submitted2017-03-30

View on ClinicalTrials.gov More Vulvar Pain Symptoms trials